Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Non-cash Items: 2023-2025

Historic Non-cash Items for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Sep 2025 value amounting to $2,686.

  • Tonix Pharmaceuticals Holding's Non-cash Items fell 95.91% to $2,686 in Q3 2025 from the same period last year, while for Sep 2025 it was $2,686, marking a year-over-year decrease of 95.91%. This contributed to the annual value of $936 for FY2024, which is 99.64% down from last year.
  • Latest data reveals that Tonix Pharmaceuticals Holding reported Non-cash Items of $2,686 as of Q3 2025, which was up 17.09% from $2,294 recorded in Q2 2025.
  • In the past 5 years, Tonix Pharmaceuticals Holding's Non-cash Items ranged from a high of $892,008 in Q1 2023 and a low of $936 during Q4 2024.
  • Over the past 3 years, Tonix Pharmaceuticals Holding's median Non-cash Items value was $65,691 (recorded in 2024), while the average stood at $209,744.
  • Data for Tonix Pharmaceuticals Holding's Non-cash Items shows a maximum YoY crashed of 99.69% (in 2025) over the last 5 years.
  • Over the past 3 years, Tonix Pharmaceuticals Holding's Non-cash Items (Quarterly) stood at $259,991 in 2023, then tumbled by 99.64% to $936 in 2024, then crashed by 95.91% to $2,686 in 2025.
  • Its last three reported values are $2,686 in Q3 2025, $2,294 for Q2 2025, and $1,784 during Q1 2025.